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ABSTRACT 
 
The molecular basis of the potent transdermal enhancement activity of a series of 
iminosulfuranes, structure provided where X = H, Cl, Br, and I, is being investigated skin 
models.   
 
 
 
It has been shown (J. Lipid Res. 46(2005), 2192-2201.) that correlations exist between 
the activity of the aforementioned transdermal penetration enhancers (TPE) and the 
extent to which these agents bind to DMPC vesicles and perturb the gel to liquid crystal 
phase transition measured by calorimetry. The degree to which the perturbation of these 
compounds extends into the bilayer interior in contrast to surface activity is unclear. To 
gain insight into this issue, the 31P NMR resonance from DMPC and DMPC-cholesterol 
unilamellar vesicles have been split by the slowly penetrating paramagnetic metal ion 
Pr+3. The extent to which this perturbation is attenuated by transdermal penetration 
enhancers has been investigated as a function of Pr+3 exposure time and iminosulfurane 
concentration. The effect of these iminosulfuranes on bilayer integrity is also being 
 explored by monitoring the induced release of carboxyfluorescein from DMPC and 
DMPC- cholesterol unilamellar vesicles.  
 
 
 
 
INDEX WORDS: transdermal penetration enhancers, iminosulfurane, NMR, DMPC, 
fluorescence, carboxyfluorescein, shift reagents. 
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1. Introduction 
 
Within the past decade, there has been an increase in the desire to administer drugs 
transdermally. The advantage of transdermal administration includes elimination of the 
first-pass effect by the liver, avoidance of the degradation of drugs by the gastrointestinal 
tract, sustained and controlled release of drugs, and greater compliance from patients.   
The skin provides an effective barrier to water loss, protects the body from unwanted 
influences, and prevents the permeation of environmental substances and the entrance of 
foreign material into the body. This barrier function of the skin is an obstacle to be 
overcome by transdermal drug delivery. In order to effectively utilize the possibilities 
created by the use of topically applied drugs, it becomes necessary to understand the 
nature of skin and mechanisms or other substances that could control the extent of its 
barrier function.  Controlling the barrier function of skin topically would allow medicines 
to permeate the skin and access the blood supply allowing for systemic delivery of drugs. 
The advantages of this type of drug delivery include targeting specific areas of the body 
and decreasing the amount of drug necessary for effect as compared to drugs taken orally. 
1.1. Structure of Skin and Its Barrier Function 
Skin, the largest organ of the body is composed of several layers including the 
epidermis and dermis (Figure 1-1). Its thickness is typically 0.1- 1.0 mm, depending on 
location in the body.  The dermis is the largest part of the skin and serves as a means of 
protection for the underlying organs and provides nutrient necessary for the growth and 
differentiation of the cells in the epidermis. The epidermis is separated from the dermis 
by a basale membrane. In the first two layers of epidermis skin cells are synthesized and 
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in the remaining layers the cells undergo transitions to finally become the 
characteristically flat corneocytes embedded in a lipid bilayer found in the stratum 
corneum (SC). The one cell thick layer just above the basale membrane is the stratum 
basale.  In this layer, epidermal stem cells undergo cell division and begin the slow 2 -3 
week journey through the higher epidermal layers until reaching the surface layer. The 
stratum spinosum, the next layer of the epidermis, is typically 2-7 cells thick with 
polyhedral shaped cells.1 These preformed stratum corneum cells are present with 
enzymes.2 The  phospholipids in the cell membranes are degraded into glycerol and free 
fatty acids, whereas the glycosylceramides are degraded into ceramides.3 In the transition 
from stratum spinosum to the stratum granulosum, the organelles are formed in the 
endoplasmic reticulum and are expelled into the extracellular space surrounding the 
cells.2 The stratum granulosum consists of 2-3 layers of diamond-shaped cells. The 
cytoplasm of these cells looks like thick granules corresponding to the name of this layer. 
These thick granules are the precursors for the corneocytes located in the SC.2 In this 
layer, the majority of the keratin, a structural protein, is produced.  In the next thin single 
layer of cells known as stratum lucidum, the cells lose their nuclei and cell organelles. As 
the epidermal cells transition to the final layer, the volume of the intercellular space 
increases from 2 cell layers to 15 layers. The outer layer of the epidermis is the stratum 
corneum (SC), also known as the horny layer, and contains 10-30 layers of flattened 
hexagonal dead skin cells where the number of layers depends on the skin location. For 
example, the skin on the abdomen has a thinner SC with fewer layers of dead skin cells 
than those found on the bottom of feet. This layer provides the main barrier function of 
the skin and is typically 0.01 mm, at most 10 percent of the total thickness of skin.  The 
3 
stratum corneum is a composed of keratinized cells in a lipid bilayer. The bilayer is 
composed of a milieu of at least six different ceramides with differing head groups and 
fatty acid chain lengths, free fatty acids (FFA) with greater than 20 carbons, cholesterol, 
and cholesterol sulfates.3 The structure is most commonly compared to a brick wall, 
hence the structure is described by a “brick and mortar model” as shown in Figure 1-2. 
The bricks in the wall represent the corneocytes or dead skin cells. The mortar in between 
the bricks is a lipid bilayer composed of a mixture of ceramides, free fatty acids, 
cholesterol, and cholesterol sulfate.   Perturbation of the stratum corneum usually results 
in a metabolic response that restores the barrier function and limits the bioavailability of 
drugs administered transdermally.4   
There are three primary routes of entry into the stratum corneum which include the 
movement of molecules via the sebaceous glands of hair follicles, across the stratum 
corneum or by way of the sweat glands.5 Movement of molecules through an intact SC 
can be subdivided into two possible routes of entry, transcellular and intercellular.5 As 
illustrated in Figure 1-3, the transcellular route involves the movement of drugs across 
alternating layers of corneocytes and lipid bilayer in order to reach viable tissue. The 
intercellular and most likely route of permeation into the SC and eventually to the blood 
supply is through the lipid matrix that surrounds the corneocytes. This disruption could 
occur through mechanisms such as compounds intercalating into the lipid bilayer or 
modifying the inherent solubility of skin lipids thereby allowing drugs to penetrate the 
SC that would normally be unable to overcome the barrier function.6  A significant effort 
has been applied to understanding the mechanism through which topically applied drugs 
can interact with the intercellular bilayer and ultimately overcome the barrier function of 
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the skin. Realistically, there are very few drugs available that have a high enough 
permeability coefficient to permeate an intact SC via passive strategies. These drugs are 
effective at low doses, have relatively small molar masses (< 400 Da) and are lipophilic.7 
There are few drugs that meet these qualifications. As a result,  passive transdermal drug 
delivery is limited to cardiovascular, hormone replacement, contraception, smoking, pain, 
and motion sickness treatment. 8 Therefore, there is a need for a method of enhancing 
drug delivery to the viable cells located beneath the SC. From this need arose a method 
known as transdermal penetration enhancement. 
1.2.  Transdermal Penetration Enhancers 
Several techniques have been developed to facilitate the movement of drugs across 
the SC and enhance transdermal drug delivery.  There are five classifications of methods 
for improving delivery: drug or vehicle interactions, vesicles and particles, removal or 
bypass of the SC, electrically assisted methods and modification of the SC.5 Drug or 
vehicle interactions involve changing the flux of the drug (Equation 1-1) where flux is 
dm/dt. If the vehicle of the drug is volatile, upon its evaporation it leaves a supersaturated 
solution of the drug in a thermodynamic state such that it has a flux greater than one 
milligram per hour and can overcome the  barrier function of the SC.5  
 
 
 
 
 
 
5 
h
KDC
dt
dm o=  
Equation 1-1 Steady-State flux.5 
dm/dt is the cumulative mass of pass a unit area of membrane per unit of time. 
D is the diffusion coefficient. 
Co is the donor drug concentration. 
K represents the partition coefficient of the solute that exists between membrane and 
bathing solution. 
h is the thickness of the membrane. 
 
Another drug vehicle interaction is one in which a vehicle permeates the skin first and 
“drags” the drug through the skin.5 The use of prodrugs involves molecules that only 
become biologically active after enzymes generate the active forms. 8 Finally, the vehicle 
can increase the solubility of the drug.5  
6 
                    
 
Figure 1-1 Structure of the Skin.9  
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Figure 1-2 “Brick and Mortar” model of the stratum corneum.10
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Figure1-3 Stratum corneum and two routes of drug penetration.5  
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Another classification of transdermal penetration involves bypassing or removing the 
SC. The SC can be bypassed using injections below the horny layer or via the hair 
follicles in the SC. Recent developments have created the resurgence of this technique 
that had been abandoned after the realization that the use of tiny needles caused skin 
damage. Adaptations of this concept include the use of hundreds of microneedles that are 
coated with the drug or contain the drug to be injected.5 This method enhances 
transdermal drug delivery five times. Follicular delivery involves the use of colloidal 
particles to introduce drugs into the epidermis via the hair follicles. 5The SC can be 
removed by chemical peels, dermabrasions, microdermabrasions, and adhesive tape 
stripping.11  
Electrically assisted methods of transdermal penetration enhancement include 
iontophoresis, ultrasound, electroporation, magentophoresis, radio waves and 
photomechanical waves. Iontophoresis uses a low electric field  to create a potential 
gradient across the membrane in order to transfer charged drugs and most recently neutral 
and zwitterionic drugs across the SC.12 The success of iontophoresis is limited by the size 
of the drug.  Some drugs are also able to overcome the barrier of the SC by ultrasound 
techniques known as sonophoresis or phonophoresis. Ultrasound is vibration at 
frequencies beyond the human audible range. The force of these sonic waves can increase 
the fluidity of the SC lipids or the drugs, apply pressure and force molecules through the 
skin, or perturb the SC lipids to facilitate the movement of drugs across the skin barrier 
1000 times greater than normal flux in absence of the sound waves.13  In a similar manner 
short high voltage electric pulses produce aqueous pathways across the lipid bilayer in an 
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application known as electroporation.7 Electroporation produces transient pores and 
enables larger molecules than the aforementioned iontophoresis. 
The final method of transdermal penetration and focus of this dissertation is the 
alteration of the SC via hydration or chemical penetration enhancers. A class of enabling 
compounds has been targeted to the stratum corneum to allow substances to cross the 
skin barrier.  These compounds are known as transdermal penetration enhancers (TPEs) 
and enhance the skin penetration of drugs via solvation, interaction with the polar head 
groups of bilayers, disruption of lateral bilayer packing, inducing transitions in the 
lamellar phases, or protein-lipid interactions.4 These compounds must be able to 
reversibly disrupt skin barrier function, be active at low concentrations, be nontoxic, and 
non-irritating.  Finally, they must be soluble in nontoxic, non-irritating media.  A variety 
of different compounds meet these qualifications including water, hydrocarbons, 
pyrrolidones, fatty acids, esters, alcohols, surfactants, amides, polyols, terpenes, 
oxazolidines, enzymes, polymers, inhibitors of lipid synthesis, azone and its derivatives, 
sulfoxides and their analogs, and synergistic mixtures of any of the aforementioned 
compounds (Figure 1-4).5   
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Figure 1-4 Representative structures of transdermal penetration enhancers. 
R is any alkyl group. 
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The action of these compounds can be subdivided into three main avenues, lipid 
action, protein alteration and promotion of partitioning of drugs (Figure 1-5). Lipid action 
is a result of fluidization, phase separation, polarity alteration and lipid extraction.8 
Fluidization occurs when hydrophobic lipid enhancers insert in between the hydrophobic 
tails of the lipids or polar enhancers interact with the polar head groups of the lipids and 
alter the highly organized structure of the lipid matrix in the SC making the bilayer more 
fluid. In phase separation TPEs, either create a water pool or form an inverted micelle in 
the multilayer lipid matrix. Polarity alteration, another lipid interaction of TPEs, occurs 
when the presence of the enhancers induces repulsion between neighboring lipid 
molecules. This repulsion disrupts the packing of the lipids and allows drugs to overcome 
the barrier function of the SC. Finally, lipids can be extracted from the bilayer to create a 
less dense lipid matrix.   Protein alteration can be a function of an enhancer interacting 
with protein structures and splitting the SC, thus removing the densely packed nature of 
the SC or denaturing the keratin found in the corneocytes and creating vacuoles 
introducing a less restrictive entry point for drugs.8 Promotion of drug partitioning 
involves the use of enhancers to increase the flux of a drug across the SC. The 
mechanism of action for many effective transdermal penetration enhancers involves more 
than one mechanism. 
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Figure 1-5  Possible mechamisms of action for chemical penetration enhancers. 8 
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Water is continuously present in the skin and maintained at constant levels. The SC 
can hold three-five times its mass in water.14 The action of skin hydration is two-fold. 
The presence of water alters the homeostatic gradient and allows for the increase in flux 
of polar molecules. Secondly, hydrating the skin raises the temperature of the site and 
swells the corneocytes; as a result the SC is less compact and drugs cross the SC more 
easily.14 Pyrrolidines and their derivatives are heterocyclic amides. At low 
concentrations, pyrrolidones denature the keratin in the corneocytes; where as at higher 
concentrations, they increase water content and increase fluidity of the lipid matrix.15 
Alkyl pyrrolidines are known to intercalate in the SC lipid bilayer, thus creating greater 
fluidity in the bilayer.16 Fatty acids disrupt the packing of the lipid bilayer and increase 
the permeability of SC.  Additionally, some fatty acids act as solvent in the SC: as the 
fatty acid enters the SC, drugs with a high affinity for the fatty acids are dragged into the 
SC.17  Alcohols have been observed to be most effective in enhancing penetration of the 
SC when the chain length is between 10-12 carbons.18 Based on these observations and 
the fact that the carbon chain on the most effective alcohols is similar to the length of the 
carbon chain on steroid nucleus of cholesterol, it is thought that the penetration 
enhancement is from the interaction of alcohols with the ceramide–cholesterol or 
cholesterol-cholesterol interactions in the SC.18  Both fatty acids and alcohols enhance 
transdermal penetration by disordering packing arrangement of SC lipid matrix and 
creating aqueous pores, and by forming complexes with drugs and making them more 
lipophilic.  
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There are four types of surfactants: cationic, anionic, nonionic, and zwitterionic.  The 
use of surfactants is limited because most irritate the skin causing tightness, inflammation 
and erythema.19 Cationic surfactants are the most damaging to the skin followed by 
anionic surfactants which are intermediate and nonionic surfactants which are the least 
irritating. There are two mechanisms of action attributed to charged surfactants, 
interaction with SC proteins, and extraction of SC lipids by micelle solubilization. 19 
Nonionic surfactants result in the least amount of damage to the SC. Consequently, their 
ability to serve as penetration enhancers is limited. However, nonionics can be used in 
conjunction with charged surfactants by forming mixed micelles and limiting the 
deleterious effect of cationic and anionic surfactants.19   Urea is an amide that is an 
effective transdermal penetration enhancer. Its mechanisms of action include serving as a 
moisturizer by increasing water content and lowering the phase transition of the lipid 
bilayers, thus allowing drugs to permeate the SC more easily.20 Long exposure time to 
urea breaks down the keratin.20 Terpenes are naturally occurring compounds made of 
varying arrangements and numbers of isoprene units. The differing structures of terpenes 
work well with different drugs. However, terpenes disrupt the lipid matrix in the SC, 
interact with the SC proteins and improve partitioning of drugs.21 Azone® (1-
dodecylazacycloheptan-2-one), a TPE currently in clinical trials, distributes 
homogeneously through the SC lipid matrix and as suggested by molecular modeling, the 
polar lactam group may force apart the polar head groups in the SC lipid matrix to 
increase membrane fluidity.22, 23 Some silicone polymers act as penetration enhancers by  
increasing the hydrophobicity of the skin surface and in doing so influence the 
partitioning of hydrophobic drugs into the SC.24 Dimethyl sulfoxide is has been widely 
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used in the medical field since the 1960’s. 25 It has a high dielectric constant because the 
polarity of the sulfur and oxygen bond. At low concentrations, DMSO denatures the 
proteins in the corneocytes and promotes swelling by displacing the water in the interior 
of the corneocytes. DMSO is most effective at concentrations greater than 60  percent.25 
At these concentrations, DMSO interacts with the polar head groups of the lipid matrix 
by displacing surrounding water molecules. As a result, channels form in the multilayer 
lipids of the SC.25  A series of iminosulfuranes isoelectronic with the sulfoxide group in 
DMSO (Figure 1-5), where X = H, Cl, Br, and I has been shown to function as potent 
TPEs in human cadaver and hairless mouse skin. However the mechanism of action is not 
understood. 26, 27  
1.3.  Biological Data of Iminosulfuranes  
Since iminosulfuranes are isoelectronic with the sulfoxide group of DMSO, these 
iminosulfuranes were screened to determine whether their biological activity is similar to 
that of DMSO.26 These compounds were initially screened using hairless mouse skin, a 
highly permeable skin model.28  If the iminosulfuranes proved active in the mouse skin, it 
could be an indication that these compounds would be active in human skin. Several 
parameters were measured in the mouse skin. Two of those parameters to be discussed 
are ERJ and Q24.  ERJ is the ratio of hydrocortisone flux across skin samples in the 
presence of selected iminosulfuranes to the flux value observed in control experiments. 
Q24 is the amount of hydrocortisone that passes through the skin in 24 hours. The results 
are summarized in Table 1.  
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Table 1-1  Permeation parameters of hydrocortisone on hairless mouse skin.23, 28 
 
Substituents ERJ Q24 (µg/cm2) 
Control 1.00 43.1 ± 5.2 
DMSO 1.37 45.5 ± 12.1 
H 0.88 32.1 ± 10 
Cl 1.51 61.9 ± 12.1 
I 1.6 121 ± 24 
Br 21 996 ± 192 
 
 
Based on the results DMSO does not appear to have significant activity in comparison to 
the control.  The iodo and chloro derivatives exhibit similar activity to DMSO. The 
bromo derivative shows activity similar to Azone®, a transdermal penetration enhancer, 
that is currently used in clinical trials.28 
Since the bromo and iodo derivatives were the most active compounds in the 
series of iminosulfuranes tested, further studies were conducted to determine whether the 
activity would be extended to human cadaver skin.23 Permeation measurements of 
hydrocortisone, in the presence of iminosulfurane derivatives, flux and Q24, are shown in 
Table 2 and support the permeation studies conducted using hairless mouse skin. 
Table 1-2 Permeation parameters of hydrocortisone on cadaver skin. 23 
 
Substituents ERJ Q24 (µg/cm2) 
Control 1 22.1 ± 5.1 
Br 17.0 319.7 ± 24.6 
I 0.8 26.0 ± 3.9 
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Figure 1-6  Structure of iminosulfuranes. 
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The permeation of the hydrocortisone in the presence of 0.4 M bromo derivative is 
significantly higher than in its absence or in the presence of the iodo derivative. 
Additionally, as concentration of the bromo derivative increases from 0.0 M to 0.4 M, 
there is a significant increase of the flux of hydrocortisone and caffeine and the amount 
of hydrocortisone  and caffeine present increases over 24 hours.23 
Because TPEs are known to cause skin irritation, cytotoxicity studies  of the iodo and 
bromo derivative were performed on epidermal keratinocytes and dermoblasts.  Cell 
viability for both the keratinocytes and the dermoblasts showed a decrease in viability 
with increasing concentrations of iminosulfuranes; however at concentrations less than 
0.2 M, there was no statistically significant effect on cell viability.23 In contrast at 
concentrations between 0.7 M and 0.9 M, there was a 50  percent decrease in cell 
viability; therefore ideal concentrations for the use of these TPEs would be less than   0.2 
M. 
1.4. Phospholipids as Models for Skin 
The barrier function of skin resides in the SC which consists of keratin filled dead 
cells surrounded by a crystalline lamellar lipid. Because the corneocytes are so dense, it is 
unlikely that TP’s applied to the surface of the skin will be able to diffuse through the 
dense protein structures. Consequently, the most likely route of entry is through the lipid 
regions surrounding the corneocytes.  In order to develop a model system for lipid matrix 
for the purpose of observing the effect of TPEs on such models, it is necessary to 
understand the nature of the lipids in the SC and make comparisons to the particular 
models of choice (DMPC and DMPC-cholesterol liposomes). 
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The lipid matrix is composed of at least nine different ceramides with lengths varying 
from 16-33 carbons, cholesterol, and free fatty acids most commonly containing 22 and 
24 carbons.3, 29 Ceramides are amphipathic molecules and are capable of forming stable 
bilayers in the presence of cholesterol and either a free fatty acid or cholesteryl sulfate.30  
The lipids in the SC form the traditional multilamellar bilayers. Freeze fracture electron 
microscope studies of human SC show that the lamellar phase has two components, one 
with a periodicity of 13 nm and the other with a periodicity of 6 nm.31 Diffraction 
patterns show that the lateral packing in absence of FFA is hexagonal. However,when 
FFA is added, the lateral packing changes to orthorhombic. Since orthorhombic packing 
is more densely packed than hexagonal, the barrier function of SC is supported by the 
presence of FFA.31  The chain lengths of ceramides are longer than those of 
phospholipids typically used in liposomes.  Additionally, the head groups of ceramides 
are small in comparison to those of phospholipids and contain different functional groups 
such as amides and hydroxyls. Consequently, they are capable of forming intermolecular 
and intramolecular hydrogen bonds which lends to the difference in the structure of the 
lipid matrix found in SC and that of phospholipids.31 Additionally, it has been shown that 
mixtures of SC lipids can be used to prepare small unilamellar vesicles in a similar way 
to phospholipid SUV’s.30 
While they are little to no phospholipids present in the SC lipid matrix, phospholipid 
bilayers provide a useful means of investigating the molecular mechanisms responsible 
for the activity of transdermal penetration enhancers.  Phospholipids are the simplest 
models that approximate some of the properties of a biological membrane. They 
structurally resemble bilayers, have a similar thickness and water permeability, as well as 
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exhibiting similar bending rigidity, surface tension, and viscosity. DMPC, a synthetic 
lipid, is often used because it undergoes phase transition at a convenient temperature 
(23.6°C).  In a model skin system consisting of DMPC unilamellar vesicles, it has been 
shown that correlations exist between the biological activity of the aforementioned 
transdermal penetration enhancers (TPE) and the extent to which these agents bind to 
DMPC vesicles and perturb the gel to liquid crystal phase transition measured by 
calorimetry.27  
1.5. Role of Cholesterol 
Cholesterol is an amphiphilic lipid whose structure differs greatly from that of 
phospholipids and ceramides. The hydrophobic portion of cholesterol is the steroid 
nucleus which consists of three cyclohexane rings and one cyclopentane ring. The 
hydroxyl group on the ring serves as the polar head of molecule. Therefore, cholesterol is 
classified as a lipid with a bulky, stiff hydrophobic tail and a small hydrophilic head.32 
Cholesterol is present in all mammalian cell membranes and is known to order bilayers. 
The presence of cholesterol in phospholipids induces a change in the morphology of the 
bilayer that is different from liquid-crystalline state or gel state and produces a new phase 
described as a liquid–ordered state.33 In a liquid-crystalline lamellar state, the 
phospholipids form a bilayer. However their motion has liquid-like properties.  In 
contrast, the lipid hydrocarbon chains in the gel state are extended and tilted slightly to 
allow for tight packing. Because of the tight packing, there is limited rotation of the 
hydrocarbons and there is a limited number of water molecules bound to the polar 
headgroups. The liquid ordered phase is characterized when the rigid steroid nucleus of 
cholesterol is located in the top portion of the hydrocarbon tail of the phospholipid and 
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the hydrocarbon tail of cholesterol is in the more disordered part of the bilayer. The 
cholesterol orders the hydrocarbon tail deep within the bilayer and limits their 
isomerizations. As a result, there a fewer kinks in the phospholipid bilayer (< 18 carbons) 
and the width of the bilayer increases.33  The ordering of the lipids also limits the 
permeability of molecules through the bilayer. In systems without cholesterol, the 
disordered kinks produce regions of packing defects. It is through the local regions of 
defects that small molecules are able to permeate the bilayer. Finally cholesterol in the 
bilayer decreases the surface area of phospholipids at the interface of water and interferes 
with the hydrogen bonding or weak electrostatic interactions that occur between 
phosphate groups of individual phospholipids.33 
Johnson et al.  have shown that there is a correlation between the flux of small (< 500 
Da) lipophilic compounds across SC lipids and DMPC and DMPC/cholesterol bilayers 
where the concentration of cholesterol is 40 mole percent. 34  Based on the compounds 
evaluated, it was shown that the DMPC and DMPC/cholesterol models exhibited the 
same qualitative effects. However, there was a departure in the quantitative analysis of 
the lateral diffusion coefficients in the models. In the DMPC model, the observed 
diffusion coefficients for the small molecules differed 15-fold from the SC lipid model.34 
There was less of a departure in diffusion coefficients of DMPC/ 40 mole  percent 
cholesterol model compared to SC lipids in that there was only a 3-fold difference.34 
Consequently, DMPC and DMPC/cholesterol preparations can provide useful qualitative 
information about the effect of iminosulfurane derivatives on the membrane integrity. For 
quantitative results more information can be obtained from DMPC/cholesterol bilayers 
than from DMPC alone. 
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1.6. Effect of Iminosulfuranes on Bilayer Integrity 
In order to understand the structure and phase behavior of lipid bilayers in the 
presence of transdermal penetration enhancers, more specifically the derivatives of  
iminosulfuranes, there are commonly used physicochemical principles such as those 
employed by differential scanning calorimetry (DSC), isothermal titration calorimetry 
(ITC), nuclear magnetic resonance (NMR), fluorescence, x-ray diffraction, and infrared 
(IR). Because lipids form highly organized structures when they are hydrated, their 
structures are dependent on various conditions such as temperature, pH, pressure, and the 
presence of perturbing compounds. DSC is a useful technique for determining the lipid 
phase transitions of membrane lipids.  The principle upon which it operates is the 
comparison between a sample and an inert reference heated linearly with time. Typically, 
the sample is a suspension of vesicles in solvent and the inert reference is water or buffer. 
As long as the lipid does not undergo a phase transition, there in no temperature change 
and the temperature differential is zero. Once the lipid undergoes a physical 
conformational change such as a phase transition, there is a temperature differential 
between the two samples; consequently the instrument changes either the power input or 
the rate of heat flow to eliminate the differential.35 After the phase transition is complete, 
the baseline reestablishes.   
It has been shown that correlations exist between the activity of the 
aforementioned transdermal penetration enhancers (TPE) and the extent to which these 
agents bind to DMPC vesicles and perturb the gel to liquid crystal phase transition 
measured by calorimetry. DMPC liposomes undergo two phase transitions, pretransition 
and main phase transition. Pretransition is characterized by transition of the lipid bilayer 
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from gel to ripple layer organization, where chain packing changes from a distorted 
orthorhombic to a hexagonal lattice.35 The main phase transition occurs when the lipid 
organization changes from ripple to fluid. Barrow et al. report the effect of 10 mole  
percent of iminosulfuranes on the pretransition and main phase transitions. 27 The 
pretransition peak broadens in the presence of 10 mole percent TPEs, which could 
indicate that they interact with the polar head groups supporting a surface interaction.27 
The bromo derivative of the iminosulfurane caused a shoulder to appear before the main 
phase transition of DMPC, which could support the destabilization of the DMPC 
bilayer.27 The introduction of the bromo derivative into a solution flowing over a DMPC 
bilayer deposited on a gold support in measurements based on the evanescent wave 
technique lead to the loss of bilayer mass, suggesting this TPE induced surface 
degradation of the bilayer had occurred (personal communication).  These findings 
indicate that the iminosulfuranes act through surface dependent interactions. However 
other results to be discussed support more than surface interaction involvement. 
Strong nuclear overhauser effect (NOE) cross peaks between the DMPC surface-
located choline N(CH3)3 moiety protons and the phenyl group protons of the TPEs are 
also observed.27 These data suggest that bilayer surface effects may contribute 
significantly to the mode of action of the compounds. However, previously reported data 
demonstrate that a NOESY cross peak appears between the terminal methyl of the lipid 
fatty acid and the phenyl protons of the bromo iminosulfurane. This cross peak suggests 
that the bromo derivative of the iminosulfurane deeply penetrates into the lipid bilayer 
causing the phenyl protons to be near the termini of the alkyl chains of DMPC bilayer. 
However, an alternative interpretation of this NOESY cross peak is that the alkyl chains 
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of lipids undergo a low-probability bending in vesicles causing the terminal methyl 
groups to be near the vesicle surface.36  In view of these observations, 31P NMR has been 
employed to evaluate whether the activity of the iminosulfuranes described in Figure 1-1 
is dependant on their deep penetration into the DMPC and the DMPC-cholesterol bilayers 
and by extension into the skin.  The degree to which the perturbation of these compounds 
extends into the bilayer interior in contrast to surface activity is unclear. 27 
Carboxyfluorescein is a fluorophore that undergoes self-quenching at high 
concentrations (100 mM) via the formation of dimers. Once the interior of the vesicle 
contained the fluorophore in excess of the threshold quenching concentration, vesicles 
exhibited minimal fluorescence.  If the addition of a TPE to the vesicle suspension 
disturbs the integrity of the bilayer, the carboxyfluorescein is released in a monomer 
fluorescent form. The release CF is expected to correlate with the perturbation of the 
bilayer. Therefore, the effects of these iminosulfuranes on bilayer integrity of DMPC and 
DMPC-cholesterol liposomes have been characterized using fluorescence spectroscopy. 
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2. Materials and Methods 
 
2.1. Materials and Methods for DMPC Preparations          
2.1.1. Materials 
Synthetic L-α-1,2-dimyristol-sn-glycero-3-phosphocholine (DMPC) was obtained 
from Avanti Polar Lipids, Alabaster, Alabama. Potassium chloride, reagent grade was 
purchased from Baker & Adamson Company, and N-[2-hydroxyethyl]piperazine-N׳-[2-
ethanesulfonic acid] (HEPES) and cholesterol, 99 percent purity, were obtained from the 
Sigma Chemical, St Louis, Missouri. Ethylene diamine tetraacetic acid (EDTA) and 
Methanol, Optima purity, were obtained from Fisher Scientific, Fair Lawn, New Jersey. 
Chloroform, OmniSolv grade, was obtained from EM Science, Gibbstown, New Jersey. 
Deuterium oxide was obtained from the Aldrich Chemical Company. Halogenated 
iminosulfuranes were synthesized by the research group of Professor L. Strekowski.28  
2.1.2. Vesicle Preparation 
Small unilamellar vesicles were prepared by rehydrating DMPC with 10 mM 
HEPES buffer with 160 mM  potassium chloride and 0.8 mM EDTA at pH = 7.5 and 
used to prepare vesicles by the technique of Bammel et al.37 The 9 mM suspension was 
premixed for 5 minutes and sonicated for 40 minutes (40 percent duty cycle) at 35 ºC 
under a stream of nitrogen. The resulting solution was centrifuged at 130,000 at 35 ºC to 
remove particulate matter. The supernatant was retained and stored in the oven at 35 ºC. 
This method produces nominally 300 Å – diameter unilamellar vesicles. 
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2.1.3. Preparation of 31P NMR Samples 
The 31P NMR spectra were obtained at 202 MHz at 35ºC using proton decoupling 
and a pulse width of 16.5 µs and acquisition time of 0.800 s.  The free induction decays 
were obtained with 6000 transients and a relaxation delay time of 2.0 s and 150 Hz line 
broadening factor. The spectra were recorded using a Varian Inova 500 MHz Fourier 
Transform spectrometer. The magnetic field strength was locked to an internal deuterium 
standard, consisting of 10 percent by volume deuterium oxide that was added to the 
supernatant retained after vesicle preparation. Probe temperature was 35 °C. All peak 
shifts were referenced to an external standard of 10 percent by volume of 
trimethylphosphate and 10 percent by volume of deuterium oxide in 10 mM HEPES 
buffer with 160 mM potassium chloride and 0.8 mM  EDTA at a pH = 7.5. An initial 31P 
NMR spectrum was acquired without the addition of the Pr3+ shift reagent. After 
obtaining the spectrum of the unilamellar vesicle solution without the shift reagent, 4.5 
mM Pr3+ was added to the sample. The spectrum was again recorded after maximum 
resonance separation was achieved, nominally after 18 h, and 10 mole percent 
iminosulfurane was then added to the sample, after which the spectrum was monitored 
over an additional 66 h. All spectra were recorded in triplicate unless otherwise noted. 
2.1.4. Preparation of  Iminosulfurane Solutions 
Three millimolar solutions of iminosulfuranes were prepared in HEPES buffer (160 
mM KCl and 10 mM HEPES) by adding no more than 4 percent ethanol to aid in 
dissolution of the iminosulfuranes. 
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2.2. Materials and Methods for 31P NMR: Iminosulfuranes and DMPC and 
Cholesterol Preparations 
2.2.1. Materials 
Cholesterol, 99 percent purity, was obtained from Sigma Chemical, St Louis, 
Missouri. The remaining materials utilized are described in section 2.1.1. 
2.2.2. Vesicle Preparation 
  DMPC and cholesterol present at 16 mole percent and 30 mole percent were 
dissolved in chloroform/methanol 2:1 by volume mixing. The phospholipids mixture was 
dried by rotary evaporation to a thin film. The resulting thin film was placed under high 
vacuum overnight to further evaporate any additional solvent. Dried films were stored at 
0 ºC under vacuum. The dried films were rehydrated with 10 mM HEPES buffer in  
160 mM potassium chloride at pH = 7.5 and used to prepare vesicles by the technique 
described in section 2.1.2. 
2.2.3. Preparation of 31P NMR Samples 
Samples were prepared as described in section 2.1.3. without EDTA. 
2.3. Materials and Methods for Carboxyfluorescein Preparations 
2.3.1. Materials 
 
A mixture of isomers of (5)-and(-6)-carboxyfluorescein (CF) was purchased from 
Molecular Probes and purified before use. Cholesterol, 99 percent purity, Sephadex G-50 
and Sephadex LH-20 were obtained from Sigma Chemical, St Louis, Missouri. Triton X-
100, electrophoresis grade was obtained from Fisher Scientific, Fair Lawn, New Jersey. 
Additional materials are referenced in section 2.1.1. 
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2.3.2. Purification of Carboxyfluorescein  
 
In order to the prepare carboxyfluorescein liposomes, the CF was recrystallized 
and purified according to a protocol written by Zuidam et al.38  In order to remove the 
polar contaminants, CF was dissolved in ethanol and boiled with activated charcoal in a 
water bath. The charcoal was filtered and the resultant solution was recrystallized with 
the addition of ice cold water and cooled slowly at -20 ºC overnight. The precipitate was 
dried with a Büchner funnel and then in a vacuum dessicator.38 
To remove the hydrophobic contaminants, a 2 M solution was prepared with the 
previously purified CF by dissolving the CF in NaOH and adjusting the pH to 7.5 by the 
addition of 6 M HCl while heating the solution to 50 ºC to aid in dissolution. The 
resultant solution was placed on a Sephadex LH-20 hydrophobic column (2.5 x 40 cm). 
The sample was eluted using HEPES buffer (10 mM HEPES, 160 mM potassium 
chloride and 0.8 mM EDTA).  Hydrophobic impurities remained on the top of the column 
as a nonfluorescent residue. The purity of the collected fractions was examined using 
silica gel thin layer chromatography with a solvent system of chloroform, methanol, and 
water with a by volume ratio of 65:25:4. The pure fractions were pooled and adjusted to 
the 100 mM for liposome preparation. The concentration of the pooled fractions was 
determined by measuring the absorbance at 492 nm, since the molar extinction 
coefficient of CF is 75,000 M-1 cm-1 at 492 nm.38 All absorbance measurements were 
made using a CARY 3G UV-visible spectrophotometer. 
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2.3.3. Calibration Curve and Self-Quenching Measurements of 
Carboxyfluorescein 
 
A set of standard dilutions was prepared from a 0.057 mM stock solution of 
carboxyfluorescein in HEPES buffer. Sequential tenfold dilutions were made 
concentrations and the fluorescence of the resulting solutions was measured using a using 
a Photon Technology Instrumentation QuantaMasterTM Spectrofluorometer. The same 
stock solution was used to prepare test solutions for assessing the range in which CF self-
quenches. Data were recorded using FeliXTM software. The excitation wavelength was 
460 nm and emission was scanned from 480- 650 nm at a 2 nm spectral bandwidth and 1 
nm step size with a 1 s integration time.   
2.3.4. Stern-Volmer Analysis 
 
Solutions of carboxyfluorescein were injected with variable amounts of bromo 
and iodo derivative using a Hamilton syringe. The fluorescence was recorded using a 
Photon Technology Instrumentation QuantaMasterTM Spectrofluorometer. Data were 
processed using FeliXTM software. The fluorescence emission of CF was recorded at 523 
nm (λex = 492 nm). 
2.3.5. Preparation of Vesicles with CF 
Vesicles encapsulated with carboxyfluorescein were prepared as described in 
section 2.1.2 and shown in Figure 2-1. However; the DMPC and DMPC-cholesterol 
preparations were suspended in a 100 mM CF solution prior to sonication.  
Unencapsulated CF was removed using a Sephadex G-50 (2.5 x 40 cm) water jacketed 
column equilibrated with HEPES buffer and pre-saturated with CF-free vesicles made 
from DMPC and DMPC-cholesterol depending upon the lipid used to encapsulate the CF.  
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The vesicles were eluted using HEPES buffer (10 mM HEPES, 160 mM potassium 
chloride and 0.8 mM EDTA). 
2.3.6. Electron Microscopy 
 
The electron micrographs were obtained using a JEOL 100CX-II Transmission 
Electron Microscope. Ten microliters of the vesicle suspension were placed on a nickel 
formvar coated grid and allowed to sit for one minute. The excess suspension was 
removed with filter paper. The remaining sample was negatively stained with 1 percent 
uranyl acetate. 
2.3.7. Determination of CF Release from Vesicles 
 
The release of CF was used to measure the integrity of the bilayer. Fluorescence 
intensities were obtained with a Photon Technology Instrumentation QuantaMasterTM 
Spectrofluorometer maintained at 35°C. Data were processed using FeliXTM software. 
The fluorescence emission of CF was recorded at 523 nm (λex = 492 nm) at a 2 nm 
spectral bandwidth and 1 nm step size with a 1 s integration time. Measurements were 
taken in one second intervals. 100 µL of vesicles encapsulated with CF was combined 
with varying concentrations and diluted to total volume of 2.2 ml with HEPES buffer (10 
mM HEPES and 160 mM potassium chloride). The emission fluorescence intensity was 
measured before and after the addition of 20 percent v/v Triton X-100 for a final 
concentration of 1 percent. 
 
Equation 2-1 Equation for the percent release of CF. 
R(t) is the percentage of CF released.  I(t) is fluorescence intensity at time t.  I(0) is initial 
fluorescence intensity and I(∞) is maximum fluorescence intensity. 
( ) ( )
( ) ( )0I-I          
100  x   0ItIR(t)
∞
−=
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Figure 2-1 Scheme for the preparation of carboxyfluorescein liposomes. 
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3. Results 
3.1. Interaction of Bromo Derivatives with DMPC Liposomes 
 
Figure 3-1 illustrates the effect of bromo iminosulfurane derivative on DMPC 
liposomes hydrated in HEPES buffer containing EDTA. The data were fit by  linear 
regression. Peaks shifts were referenced to an external trimethylphosphate standard in 
HEPES buffer with EDTA (see the Materials and Methods section 2.1.3). In DMPC 
vesicles containing no cholesterol, the bromo derivative decreases the 31P resonance 
separation at a rate that is only marginally greater than that due to vesicle aging 
(Figure 3-1).  At 0.1 mole percent, the bromo derivative appears to inhibit the 
reduction due to the normal aging as observed in the control. The vesicles do exhibit 
an aging effect. However, when the bromo derivative concentration is 0.2 mole 
percent or greater, the peak separation decay rate is greater than the decay of the 
vesicles alone. A plot of the slopes from the regression fit is plotted versus mole 
percent (Figure 3-2).  At  5 and 10 mole percent, there is a significant difference in 
the slopes, indicating an increase in the decay of peak separation in the presence of 
bromo iminosulfuranes at these concentrations. 
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Figure 3-1 Interaction of varying concentrations of bromo iminosulfurane 
derivative with DMPC liposomes in HEPES buffer with EDTA.  
Data were fit by linear regression. Peaks shifts were referenced to an external 
trimethylphosphate standard in HEPES buffer with EDTA (see the Materials and 
Methods section 2.1.3). 
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Figure 3-2 Plot of slopes of varying concentrations of bromo iminosulfurane 
derivative of DMPC liposomes in HEPES buffer with EDTA.  
Data were fit by linear regression. Peaks shifts were referenced to an external 
trimethylphosphate standard in HEPES buffer with EDTA (see the Materials and 
Methods section 2.1.3). 
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3.1. Interaction of Varying Concentrations of Iodo Derivatives with DMPC 
Liposomes 
The decay of peak separation of varying concentrations of iodo iminosulfurane 
derivative of DMPC liposomes in HEPES buffer with EDTA was plotted (Figure 3-
3).  The data were fit using second order polynomials. At 0.1 mole percent, the iodo 
derivative appears to inhibit the reduction due to the normal aging as observed in the 
control. In DMPC vesicles containing no cholesterol, concentrations of at least 1 mole  
percent iodo derivative also decrease the 31P resonance separation, but at a rate that is 
only marginally greater than that due to vesicle aging (Figure 3-3).  Increasing the 
concentration of the iodo derivative increases the decay of peak separation. However, 
in contrast to the control, the peaks do not collapse to zero within 54 h, but reach a 
plateau. 
3.2. Summary of Interactions of Iminosulfurane Derivatives with DMPC 
Liposomes at 10 mole Percent and 20 mole Percent 
 
After 10 h, the 10 mole percent of the bromo derivative accelerates the decay of 
peak separation. The peak separation versus time plot exhibits saturation when the 
chloro or iodo TPE derivatives are present (Figures 3-3 and 3-4). The chloro 
derivative appears to inhibit the reduction due to the normal aging as observed in the 
control.  The 31P peak separation corrected for the aging effect exhibits saturation 20 
h after the bromo derivative has been added. The effect of the chloro and iodo 
derivatives could not be distinguished from the aging effect in the control, TPE–free, 
DMPC vesicles. 
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Figure 3-3 Interaction of varying concentrations of iodo iminosulfurane derivatives 
with DMPC liposomes in HEPES buffer with EDTA.  
Data fit using a 2nd order polynomial. Peaks shifts were referenced to an external 
trimethylphosphate standard in HEPES buffer with EDTA (see the Materials and 
Methods section). 
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Figure 3-4 Interaction of iminosulfurane derivatives with DMPC liposomes.  
Data were fit using 2nd order polynomial. Peaks shifts were referenced to an external 
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section). 
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3.3. Effect of Praseodymium Ion on DMPC Liposomes 
 
Since the EDTA present in the HEPES buffer chelates a portion of the Pr3+, 
removal of the EDTA requires significantly less shift reagent. A plot of shift reagent 
versus 31P chemical shift separation between the inside and outside phosphate resonances 
was fit with a 2nd order polynomial (Figure 3-5).  Peak separation increases with an 
increase in concentration of shift reagent, but approaches a maximum with 4.5 mM shift 
reagent.  Results were similar to those observed with the addition of calcium and 
lanthanum ions to outside of the phospholipid vesicles formed from egg 
phosphatidylcholine.39  Hutton et al. also showed the effect praseodymium encapsulated 
in the interior of the vesicles on peak separation. These titration curves were used to 
determine inner and outer radii of lipid bilayers and had a similar shape as the curve in 
Figure 3-5.  Figure 3-6 shows the spectra of DMPC without EDTA in the buffer after the 
addition of 0.90 mM Pr3+. The resonances from the inner and outer leaflet collapse within 
25 h. After the addition of 1.35 mM Pr3+and 4.5 mM Pr3+, the resonances collapse within 
33 h as shown in Figures 3-7 and 3-8, respectively. Decays of peak separation of DPMC 
liposomes without EDTA in the buffer vary with different concentrations of Pr3+. The 
data were fit with linear regressions (Figure 3-9). Increasing the shift reagent 
concentration increased the rate of decay. 
3.4. Effect of  Bromo and Iodo Derivatives on DMPC Liposomes in Absence of 
EDTA in the Buffer 
 
Figure 3-8 shows the spectra of DMPC after the addition of 4.5 mM Pr3+ over 
time. Spectrum (a) was obtained before the addition of shift reagent. Spectra (b-f) were 
obtained in over a period of 42 h.  The spectra in Figures 3-10 and 3-11 show the effect 
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of 10 mole percent bromo iminosulfurane derivative and 10 mole percent iodo 
iminosulfurane with DMPC liposomes in HEPES buffer, respectively.  In spectrum (a) 
are the phosphorus signals with no shift reagent. Spectra (b-j) illustrate the effect of the 
appropriate derivative as a function of time.  Peaks shifts were referenced to an external 
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section 
2.1.3). The peak separations obtained from these spectra were plotted as a function of 
time (Figure 3-13). The data were fit by a 2nd order polynomial. In DMPC vesicles 
containing no cholesterol, the bromo derivative decreases the 31P resonance separation to 
zero within 51 h, whereas the decrease in the peak separation caused by the presence of 
the iodo derivative was more than half of its original value. The decay rates attributed to 
the effect of the bromo and iodo derivatives were greater than in their absence. 
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Figure 3-5  31P chemical shift separation between inside and outside phosphate 
resonances versus the concentration of Pr 3+. 
The data was fit with a 2nd order polynomial. 
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Figure 3-6 Spectra of DMPC liposomes with 0.90 mM Pr3+. 
Spectra (a-e) were obtained after the addition of 0.90 mM PrCl3. Peaks shifts were 
referenced to an external trimethylphosphate standard in HEPES buffer (see the Materials 
and Methods section 2.1.3). 
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Figure 3-7 Spectra of DMPC liposomes with 1.35 mM Pr3+. 
Spectra (a-d) were obtained after the addition of 1.35 mM PrCl3. Peaks shifts were 
referenced to an external trimethylphosphate standard in HEPES buffer (see the Materials 
and Methods section 2.1.3). 
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Figure 3-8  Spectra of DMPC liposomes with no EDTA.  
(a) is the phosphorus signal with no Pr3+. Spectra (b-f) were obtained after the addition of 
4.5 mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard in 
HEPES buffer (see the Materials and Methods section 2.1.3). 
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Figure 3-9 The peak separation of DMPC decays in absence of iminosulfurane 
derivatives at varying concentrations of Pr3+.  
The data were fit by a linear regression. 
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3.5. Comparisons of Decay Rates with DMPC Liposomes Containing Varying 
Concentrations of Cholesterol  
 
The 31P NMR spectra were acquired for liposomes containing varying mole percent of 
cholesterol, more specifically 8.8, 16, 27, and 35 as described in Material and Methods 
section 2.1.3. Figures 3-13, 3-14, 3-15, and 3-16 show the spectra these liposomes 
containing 8.8, 16, 27, and 35 mole percent of cholesterol, respectively. After the 
addition of 0.45 mM of Pr 3+, the decay of peak separation was monitored over time. The 
resonances associated with the inner and outer leaflet of liposomes containing 8.8 mole 
percent collapsed to one peak within 25 h. The peak separation of liposomes containing 
16 mole  percent and 27 mole  percent decreased to 5.5 ppm over 84 h and 8.97 ppm over 
66 h respectively. The liposomes containing 35 mole percent cholesterol exhibited the 
smallest decay of peak separation with resonances separated by 11 ppm after 92 h.   The 
stability of the liposomes varied with concentration of cholesterol as shown by Figure 3-
17.  The peak separations were plotted as a function of time for the different liposomes 
preparations. The data from 8.8 and 16 mole percent were fit with a 2nd order polynomial, 
whereas the data from 27 and 35 mole percent were fit with a 3rd order polynomial. 
Increasing the concentration of cholesterol stabilizes the liposome, thereby minimizing 
the decrease in peak separation over time. 
3.6. 31P NMR of DMPC and 16 Mole Percent Cholesterol  
 
Figure 3-7 shows the peak separation of DMPC liposomes containing 16 mole  
percent cholesterol over time. Spectrum (a) is the 31P resonance in absence of shift 
reagent. Within minutes of the addition of the slowly penetrating shift reagent, the single 
48 
phosphorus peak is split into two peaks, allowing for differentiation of the inner and outer 
leaflet. However, maximum peak separation occurs within 18 h of the addition of 
Pr3+(Spectra b-c).  
Figure 3-8 shows the control which is the peak separation of DMPC liposomes 
containing 16 mole  percent cholesterol over time. Spectrum (a) is the resonance of the 
phosphorus head group in absences of shift reagent. Within minutes of the addition of the 
slowly penetrating shift reagent, the single phosphorus peak is split into two peaks 
allowing for differentiation of the inner and outer leaflet. However, maximum peak 
separation occurs within 18 h of the addition of Pr3+(Spectra b-d). The peak separation is 
monitored over the next 66 h (Spectra e-n). After 84 h the peak separation decreases to 
5.5 ppm.  
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Figure 3-10 Spectra of DMPC liposomes with no EDTA after addition of  10 mole  
Percent bromo compound. 
(a) is phosphorus signal with no Pr3+. Spectra (b-n) were obtained after the addition of 4.5 
mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard in 
HEPES buffer (see the Materials and Methods section 2.1.3). 
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Figure 3-11 Spectra of DMPC Liposomes with no EDTA after addition of 10 mole  
percent Iodo compound. 
(a) is phosphorus signal with no Pr3+. Spectra (b-j) were obtained after the addition of 
0.45 mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard 
in HEPES buffer; see the Materials and Methods section 2.1.3. 
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Figure 3-12 The effect of 10 mole percent bromo and iodo derivatives on 31P 
resonances seen in DMPC liposomes without EDTA. 
Data were fit with 2nd order polynomials. 
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Figure 3-13 Spectra of  DMPC liposomes with 8.8 mole  percent cholesterol. 
(a) is phosphorus signal with no Pr3+. Spectra (b-i) were obtained after the addition of 4.5 
mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard in 
HEPES buffer (see the Materials and Methods section 2.1.3). 
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Figure 3-13 DMPC and 16 mole percent cholesterol. 
(a) is phosphorus signal with no Pr3+. Spectra (b-n) were obtained after the addition of 
0.45 mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard 
in HEPES buffer (see the Materials and Methods section 2.1.3). 
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Figure 3-14 Spectra of  DMPC iposomes 27 mole  percent cholesterol.  
(a) is phosphorus signal with no Pr3+. Spectra (b-k) were obtained after the addition of 
0.45 mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard 
in HEPES buffer (see the Materials and Methods section 2.1.3). 
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Figure 3-15 Spectra of  DMPC liposomes with 35 mole percent cholesterol. 
(a) is phosphorus signal with no Pr3+. Spectra (b-n) were obtained after the addition of 
0.45 mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard 
in HEPES buffer (see the Materials and Methods section 2.1.3). 
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Figure 3-16 Decay of 31P resonance separation as a function of cholesterol 
concentration. 
8.8 mole  percent cholesterol was fit with a 2nd order polynomial, whereas  16  mole   
percent 27 mole  percent and 35 mole  percent were fit with a 3rd order polynomial. 
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Figure 3-9 illustrates the spectra obtained from the interaction of 10 mole percent 
bromo  derivative with DMPC containing 16 mole percent cholesterol.  After the 
maximum peak separation between the inner and outer leaflet was achieved, 10 mole 
percent bromo iminosulfurane was added (Figure 2.3-5). The effect of the bromo 
derivative on the splitting was monitored as a function of time over a period of 66 h. In 
DMPC vesicles containing 16 mole percent cholesterol, the addition of the bromo 
derivative causes a collapse of the splitting to zero within 30 h.  
Figure 3-10 illustrates the effect of the iodo derivative after the maximum peak 
separation between the inner and outer leaflet was achieved (Spectra b-c). The effect of 
the  addition of 10 mole percent iodo iminosulfurane on the splitting was monitored as a 
function of time over a period of 66 h. The addition of the iodo derivative causes a 
collapse of the splitting to 2.5 ppm within 66 h.  
The change in resonance separation in the presence of 10 mole percent chloro 
derivative is plotted as a function of time in Figure 3-11. The reduction in the splitting 
induced by the chloro derivative occurs over a longer period of time. 
The change in resonance separation in the presence of 10 mole percent hydrogen 
derivative is plotted as a function of time in Figure 3-12. The reduction in the splitting of 
induced by the hydrogen derivative occurs over a longer period of time than that of 
bromo and iodo derivatives. 
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Figure 3-17  The interaction of praseodymium with DMPC and 16 mole percent 
cholesterol. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectra (c) is 18 h after the addition of 0.45 mM Pr3+.  
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Figure 3-18 DMPC and 16 mole percent cholesterol  with 10 mole percent bromo 
derivative. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after 
the addition of 0.45 mM Pr3+. Spectra (e-l) were obtained after the addition of 10 mole 
percent  bromo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts 
were referenced to an external trimethylphosphate standard in HEPES buffer (see the 
Materials and Methods section 2.1.3). 
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Figure 3-19 DMPC and 16 mole percent cholesterol with 10 mole percent iodo 
derivative. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after 
the addition of 0.45 mM Pr3+. Spectra (e-o) were obtained after the addition of 10 mole 
percent iodo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts 
were referenced to an external trimethylphosphate standard in HEPES buffer (see the 
Materials and Methods section 2.1.3). 
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Figure 3-20 DMPC and 16 mole percent cholesterol with 10 mole percent chloro 
derivative. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after 
the addition of 0.45 mM Pr3+. Spectra (e-o) were obtained after the addition of 10 mole 
percent  chloro derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts 
were referenced to an external trimethylphosphate standard in HEPES buffer (see the 
Materials and Methods section 2.1.3). 
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Figure 3-21 DMPC and 16 mole percent cholesterol. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after 
the addition of 0.45 mM Pr3+. Spectra (e-p) were obtained after the addition of 10 mole 
percent hydrogen derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks 
shifts were referenced to an external trimethylphosphate standard in HEPES buffer (see 
the Materials and Methods section 2.1.3). 
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3.7. Summary Analysis of Iminosulfurane Derivatives with DMPC Liposomes 
Containing 16 Mole Percent Cholesterol  
 
The change in resonance separation in the absence of transdermal penetration 
enhancers is plotted as a function of time in the control and demonstrates the effect of 
these enhancers on the splitting of the 31P resonances associated with the inner and outer 
leaflet of the vesicle bilayer. After 84 h, the resonances remain separated by 5 ppm in the 
control spectrum. The addition of the bromo derivative causes a collapse of the splitting 
to zero within 30 h as shown. The reduction in the splitting induced by the iodo, chloro, 
and hydrogen derivatives occurs over longer periods of time, but at a rate that is only 
marginally greater than that due to the control as shown in Figure 3-13.  Lines drawn 
through the data points were obtained by polynomial regression analyses. 
3.8. Effect of 30 mole percent Cholesterol on DMPC Liposomes 
 
Increasing the cholesterol content of the DMPC vesicles above 16 mole percent 
further reduces the rate at which the splitting is collapsed by the iminosulfuranes. The 
change in resonance separation in the absence of transdermal penetration enhancers is 
plotted as a function of time in Figure 3-14. After 84 h, the resonances remain separated 
by 5 ppm in the control spectrum. 
The effect of the bromo derivative at 10 mole percent could not be distinguished from 
the aging effect in the control. However, increasing the concentration of the bromo 
derivative to 20 mole  percent decreases the rate of 31P resonance separation greater than 
that of the control. 
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Figure 3-22 Interaction of iminosulfurane derivatives with DMPC and 16 mole 
percent cholesterol liposomes.  
Data fit with polynomial fit. Peaks shifts were referenced to an external 
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section 
2.1.3). 
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Figure 3-23 DMPC and 30 mole percent cholesterol. 
 (a) is phosphorus signal with no Pr 3+.  Spectra (b-n) were obtained after the addition of 
0.45 mM PrCl3. Peaks shifts were referenced to an external trimethylphosphate standard 
in HEPES buffer (see the Materials and Methods section 2.1.3). 
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Figure 3-24 DMPC and 30 mole percent cholesterol interaction with bromo 
derivative. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after 
the addition of 0.45 mM Pr3+. Spectra (e-q) were obtained after the addition of 10 mole 
percent   bromo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts 
were referenced to an external trimethylphosphate standard in HEPES buffer (see the 
Materials and Methods section 2.1.3). 
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Figure 3-25 DMPC and 30 mole percent cholesterol with 20 Percent bromo 
derivative. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after 
the addition of 0.45 mM Pr3+. Spectra (f-r) were obtained after the addition of 20 mole 
percent  bromo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts 
were referenced to an external trimethylphosphate standard in HEPES buffer (see the 
Materials and Methods section 2.1.3). 
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Figure 3-26 Interaction of bromo iminosulfurane derivatives with DMPC and 30 
mole percent cholesterol liposomes with varying concentrations. 
Data fit with polynomial fit. Peaks shifts were referenced to an external 
trimethylphosphate standard in HEPES buffer(see the Materials and Methods section 
2.1.3). 
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Figure 3-27 DMPC and 30 mole percent cholesterol with addition of 10 percent iodo 
derivative. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after 
the addition of 0.45 mM Pr3+. Spectra (e-o) were obtained after the addition of 10 mole 
percent iodo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts 
were referenced to an external trimethylphosphate standard in HEPES buffer (see the 
Materials and Methods section 2.1.3). 
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Figure 3-28 DMPC and 30 mole percent cholesterol  with  20 percent iodo 
derivative. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after 
the addition of 0.45 mM Pr3+. Spectra (e-r) were obtained after the addition of 20 mole 
percent  iodo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts 
were referenced to an external trimethylphosphate standard in HEPES buffer (see the 
Materials and Methods section 2.1.3). 
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Figure 3-29 Interaction of different concentrations of iodo derivatives with DMPC 
and 30 mole percent cholesterol liposomes. 
 Data were fit with 3rd order polynomial fit. Peaks shifts were referenced to an external 
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section 
2.1.3). 
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Figure 3-30 DMPC and 30 mole percent cholesterol with 10 mole percent chloro 
derivative. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after 
the addition of 0.45 mM Pr3+. Spectra (f-r) were obtained after the addition of 10 mole 
percent  chloro derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts 
were referenced to an external trimethylphosphate standard in HEPES buffer (see the 
Materials and Methods section 2.1.3). 
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Figure 3-31 DMPC and 30 mole percent cholesterol with 20 mole  percent chloro 
derivative. 
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM 
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after 
the addition of 0.45 mM Pr3+. Spectra (e-r) were obtained after the addition of 20 mole 
percent chloro derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts 
were referenced to an external trimethylphosphate standard in HEPES buffer (see the 
Materials and Methods section 2.1.3). 
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Figure 3-32 Interaction of chloro iminosulfurane derivatives with DMPC and 30 
mole percent cholesterol liposomes.  
Data were fit with 3rd order polynomial. Peaks shifts were referenced to an external 
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section 
2.1.3). 
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Figure 3-33 Interaction of iminosulfurane derivatives with DMPC and 30 mole 
percent cholesterol liposomes.  
Data were fit with 3rd order polynomial. Peaks shifts were referenced to an external 
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section 
2.1.3). 
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The effect of the iodo derivative at 10 mole  percent could not be distinguished from the 
aging effect in the control. However, increasing the concentration of the iodo derivative 
to 20 mole  percent decreased the rate of 31P resonance separation collapse greater than 
that of the control. 
3.9. Calibration Curve and Self Quenching of Carboxyfluorescein 
Emission spectra of CF were measured at the λ max , 523 nm. Fluorescence of CF 
is linear over the range 3-30 uM (data not shown). 38 A plot of concentration of CF versus 
the fluorescence plotted outside of the linear region shows that at concentrations greater 
than 3 mM, the fluorescence begins to quench. Figure 3-34 shows the decrease in 
fluorescence as molar concentrations of CF exceed 3 mM. At 100 mM of CF, 
fluorescence is 95 percent quenched and in excess of 200 mM, fluorescence is 97-98 
percent quenched. 40 
 
 
 
77 
5 105
1 106
1.5 106
2 106
2.5 106
3 106
3.5 106
4 106
0 20 40 60 80 100 120 140
Fluorescence of CF as a Function of Concentration
Fl
uo
re
sc
en
ce
 (c
ou
nt
s/
se
c)
Concentration of CF (mM)
 
Figure 3-34 Fluorescence of carboxyfluorescein as a function of concentration. 
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3.10. Stern-Volmer Plots of Bromo and Iodo Derivatives 
Halogenated compounds such as iodine and bromine are known to exhibit the 
heavy atom effect. The heavy atom effect causes the excited state of a fluorophore to be 
deactivated by collisional quenching. As fluorophores in the excited singlet state collide 
with halogenated compounds, their energy is transferred to the excited triplet state 
through intersystem crossing.41 This process is defined by equation 3-1, which assumes 
that there is only one class of fluorophores present and that they are equally accessible to 
quenching.41 A plot of the ratio fluorescence in the absence of quencher to fluorescence 
in the presence of quencher versus concentration has a y-intercept of one. The slope of 
the line is the dynamic quenching constant.  
 
To determine whether the aforementioned iminosulfuranes interfere with the 
fluorescence of carboxyfluorescein, the change in fluorescence takes into account the 
dilution effect that occurs upon addition of transdermal agents.  Figures 3-25 and 3-26 are 
the plots of the ratio fluorescence of CF in the absence of quencher to fluorescence of CF 
in the presence of quencher versus concentration of quencher, where the quenchers are 
the bromo compound and the iodo compound, respectively. The slope of the Stern-
Volmer plot is 0.0028 µM -1 for the bromo derivative and -0.00010 µM -1 for the iodo 
derivative; hence KD, the dynamic quenching constant is zero. The addition of varying 
concentrations of quencher which is either the bromo compound or the iodo compound in 
the micromolar quantities has no significant effect on fluorescence of CF.   
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[Q]1][1  oτqo kQK
F
F
D +=+=  
Equation 3-1 Stern-Volmer equation for collisional quenching.41 
Fo is the fluorescence in absence of the quencher. 
F is the fluorescence in the presence of the quencher. 
KD is the Stern-Volmer quenching constant or dynamic quenching constant. 
[Q] is the concentration of the quencher. 
Kq is the bimolecular quenching constant. 
τo is the  lifetime of the fluorophore in absence of the quencher. 
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Figure 3-35 Stern-Volmer plot for CF-bromo derivative system quenching of 
carboxyfluorescein.  
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Figure 3-36 Stern-Volmer plot for CF- iodo derivative system quenching of 
carboxyfluorescein.  
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3.11. Structural Confirmation of Vesicles Encapsulated with CF 
In order to monitor the vesicle preparation, electron micrographs were taken of 
CF-free vesicles and vesicles encapsulated with CF. The CF-free vesicles have an 
average diameter of 300 Å (Figure 3-38a), whereas the average diameter of vesicles 
containing CF increases to 600 Å (Figure 3-38b). The encapsulation of CF doubles the 
diameter of the vesicles. Similar results were observed with the encapsulation of   
potential cyanine sensitive dyes into DMPC vesicles; where the vesicle diameter also 
increased.37  
3.12. Carboxyfluorescein Release of DMPC Vesicles with Triton X-100 
To test the effectiveness of a membrane disruptor, a fluorophore such as CF is 
encapsulated in the interior of the vesicles at high concentrations. The fluorophore and 
vesicle will be sonicated to encapsulate the dye. The sonicate will then be passed through 
a chromatography column to remove the unencapsulated dye. Once the interior of the 
vesicle contains the fluorophore in the appropriate concentration, the vesicles should 
exhibit no fluorescence. Next the TPE can be applied to the vesicles. As the lipid bilayer 
is disrupted, CF will leach out causing a measurable increase in fluorescence. The 
increase in fluorescence is used to calculate the percent of CF released and provides a 
measure on the effect of the membrane disruptor on the integrity of the bilayer. 
Detergents are known disruptors of bilayers. When 8.5 mM Triton X-100, a 
nonionic surfactant is added to the DMPC liposomes encapsulated with CF, the CF leaks 
out over time and eventually all of the CF is released and quenching is relieved, causing 
the amount fluorescence released to increase to 100 percent within 20 h (Figure3-39).   
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3.13. The Effect Iminosulfurane Derivatives on Bilayer Integrity Measured 
by Carboxyfluorescein Release from DMPC Vesicles  
The bromo derivative at 3.1, 6.1, and 16.1 mole percent was added to vesicles 
encapsulated with CF and the resulting fluorescence of CF was monitored for 20 minutes 
in one second intervals (Figure 3-40). The percentage of CF released was calculated the 
according to equation 1-1. The maximum percent release was achieved within the time of 
hand mixing. After the addition of iminosulfurane, the percent release of CF achieved a 
maximum and decreases and reached a plateau.  Addition of 3.1 percent bromo released   
23 percent of CF. Doubling the amount of bromo to 6.1 percent caused the percentage of 
CF released to be 39 percent, almost twice that achieved with 6.1 percent. The addition of 
16.1 percent bromo released 61 percent of the encapsulated CF. 
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Figure 3-37 Electron micrographs. 
(a) is DMPC vesicles. The scale bar is 200 nm. (b) is CF encapsulated in DMPC vesicles.  
The scale bar is 500 nm. For experimental conditions, see Material and Methods. 
(b) 
(a) 
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Figure 3-38 Release of carboxyfluorescein in DMPC with addition of 8.5 mM Triton 
X-100 as a function of time. 
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3.14. The Effect Bromo and Iodo Iminosulfurane Derivatives on Bilayer 
Integrity Measured by Carboxyfluorescein Release from DMPC Vesicles 
Containing 16 Mole Percent Cholesterol  
 
The percent release of CF was monitored as a function of time in one second 
intervals for 25 minutes (Figures 3-41 and 3-42). The maximum percent release were 
achieved within the time of mixing. After the maximum release, the percent release of CF 
decreases and reached a plateau. In the DMPC vesicles containing 16 mole percent 
cholesterol, there was no CF release with the addition of 3.1 percent bromo derivative. 
Doubling the amount of bromo derivative to 6.1  percent caused the release of 
approximately 15 percent of CF. Thirty five percent of CF was released upon the addition 
of 16  percent bromo derivative. The iodo derivative resulted in an increase of 8.9 percent 
CF release when 3.5 percent iodo is added. Doubling the amount of iodo added increased 
the amount of CF released to 25 percent. However, an increase of iodo to 19.1 percent 
provided only a nominal increase in the percentage of CF released. 
3.15. The Effect Bromo and Iodo Iminosulfurane Derivatives on Bilayer 
Integrity Measured by Carboxyfluorescein Release from DMPC Vesicles 
Containing 30 Mole Percent Cholesterol  
 
Vesicles containing 30 mole percent cholesterol were treated with varying 
concentrations of bromo and iodo iminosulfuranes and monitored in one second intervals 
for 25 minutes (Figures 3-43 and 3-44). The addition of 3.1 and 6.1 mole percent bromo 
caused 23 percent  and 31  percent CF to be released, respectively.  The addition of 16.1 
mole percent of bromo released 57 percent of the CF. Conversely, the addition of iodo 
derivative releases less CF than the bromo derivative. The addition of 3.5  percent iodo 
released 17 percent CF. Increasing the concentration from 7.0 mole  percent to 19 mole  
percent slightly increased the amount of CF released (from 27  percent to 32 percent).  
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Figure 3-39 The percent of CF released as a function of Triton X-100 concentration.
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Figure 3-40 Percent changes in release of encapsulated carboxyfluorescein from 
DMPC vesicles in the presence of increasing concentrations of bromo 
iminosulfurane derivative. 
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Figure 3-41 Percent changes in release of encapsulated carboxyfluorescein from 
DMPC -16 mole  percent cholesterol in the presence of increasing concentrations of 
bromo derivative of iminosulfurane.  
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Figure 3-42 Percent changes in release of encapsulated carboxyfluorescein from 
DMPC -16 mole  percent cholesterol vesicles in the presence of increasing 
concentrations of iodo iminosulfurane  derivative. 
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Figure 3-43 Percent changes in release of encapsulated carboxyfluorescein from 
DMPC -30 mole  percent cholesterol vesicles in the presence of increasing 
concentrations of bromo iminosulfurane  derivative. 
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Figure 3-44  Percent changes in release of encapsulated carboxyfluorescein from 
DMPC -30 mole  percent cholesterol in the presence of increasing concentrations of 
iodo derivative of iminosulfurane. 
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3.16. Summary of Carboxyfluorescein Release from Vesicles Containing Varying 
Concentrations of Cholesterol with Bromo and Iodo Iminosulfuranes 
Derivatives 
 
Figure 3-45 illustrates the effect of the bromo and iodo derivatives on liposomes 
containing different concentrations of cholesterol.  Percentage of CF released increases 
linearly with the concentration of bromo added in all of the observed DMPC 
preparations, DMPC, DMPC with 16 mole percent cholesterol, and DMPC with 30 mole  
percent cholesterol.  The greatest amount of CF is released in the DMPC vesicles 
containing no cholesterol. The effect of increasing the amount of iodo in the cholesterol 
preparations has a small effect on the percentage of CF released.  
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Figure 3-45 Percent changes in release of encapsulated carboxyfluorescein from 
liposomes in the presence of increasing concentrations of the bromo iminosulfurane 
derivative 
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Figure 3-46 Percent changes in release of encapsulated carboxyfluorescein from 
DMPC - cholesterol liposomes in the presence of increasing concentrations of iodo 
iminosulfurane derivative. 
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4. Discussion of Results 
4.1. DMPC Bilayers Interactions with Iminosulfurane Measured by Calorimetry 
 
Barrow et al. examine the effects of chloro, bromo and iodo iminosulfurane derivatives 
on the two phase transitions of DMPC liposomes.  During the first transition known as 
pretransition phase, the polar headgroups are believed to reorient and the lipid bilayer 
transitions from the gel to ripple layer organization. The main phase transition occurs 
when the lipid organization changes from ripple to fluid.27 The pretransition peak 
broadens and becomes part of the baseline in the presence of 10 mole percent 
iminosulfurane derivatives. The disappearance of the pretransition peak could indicate 
that the mode of action of the iminosulfuranes is a surface interaction. The main phase 
transition occurs when the lipid organization changes from ripple to fluid.  The bromo 
derivative of the iminosulfurane caused a shoulder to appear before the main phase 
transition of DMPC at a lower temperature. Since simulations of these data could not be 
reproduced using a single two state model, a multi-two state model was used. This  multi-
two state model could be indicative of the formation of multiple melting domains and 
consequently, the destabilization of the DMPC bilayer by the bromo derivative.27 
Additionally when the concentration of the chloro derivative was one mole percent,  the 
profile was similar to the control. For the bromo and iodo derivatives, the profiles could 
be fit to a single two state model. Therefore, it is possible that the perturbation of the 
bilayer by iminosulfurane derivatives is concentration dependant. 
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4.2. Evaluation of Bilayer Penetration of Lipid Bilayer using NOESY  
 
Using the Nuclear Overhauser Effect Spectroscopy (NOESY), strong cross peaks were 
found to exist between the phenyl protons of the iminosulfurane and the protons of the 
unresolved methylenes in the DMPC hydrophobic tail. 27 Table 4-1 shows the cross peak 
volumes as a function of the type of iminosulfurane derivatives at 10 mole percent. The 
cross peak volume is largest for the most biologically active compound, the bromo 
iminosulfurane. This observation suggests that there is a greater population of the bromo 
derivative in the bilayer. The cross peak volume of the iodo derivative is less that than 
that of the bromo derivative, which suggests that the iodo iminosulfurane does not 
interact with the fatty acid portion of the bilayer to the extent that the bromo derivative 
does. 
Table 4-1 NOESY cross peak volumes of iminosulfurane derivatives.27 
 
 
Substituent 
Cross Peak Volume  
Methylene (mm3) 
H 0 
Cl 2.10 
I 5.79 
Br 9.08 
 
 
There are strong cross peaks between the N-methyl protons and the phenyl protons of 
the bromo and iodo derivatives at 10 mole percent. However, the same cross peaks are 
absent in the presence of 10 mole percent chloro derivative and one mole percent  bromo 
and iodo derivatives.27  These observations further support a concentration dependant 
effect on bilayer perturbation.  The most notable result of this series of experiments is the 
appearance of a cross peak between the phenyl protons of the bromo derivative and the 
terminal methyl of the lipid tail, which suggests that the bromo derivative is able to 
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deeply penetrate into the bilayer.27 All NOESY measurements are based on the 
assumption that the buildup rates are identical for all iminosulfuranes.27 
4.3. Principles of 31P NMR  
 
 Some atomic nuclei have magnetic moments that are sensitive to their environment 
and interact weakly with them. NMR exploits this propensity for dimagnetic nuclei such 
as 1H, 2H, 13C, 14N, 19F and 31P to interact with magnetic fields. Because most molecules 
contain at least one isotope with a magnetic moment, this interaction is useful for gaining 
molecular information and kinetic information about molecules with little disruption on 
the observed species.  
When a magnetic nucleus, such as phosphorus is placed in a magnetic field, it adopts 
one of two possible orientations. The nucleus should either be in the same direction as the 
applied field (+½) or in the opposite direction of the applied field (-½).  The nucleus has a 
lower energy level when it is parallel to the field and a higher energy level when it is 
antiparallel to the field. Sample magnetization from the NMR comes from the different 
distribution of nuclear dipoles in the two energy states. Because the energy difference the 
phosphorus nuclei is small, the population difference of energy levels is parts per million.  
There are two ways in which NMR spectrum can be obtained, continuous wave and 
pulse. Modern NMR spectroscopy employs pulse techniques. The data collected is in the 
form of free induction decay (FID).  Fourier transform converts the FID from time 
domain into a spectrum in the frequency domain.  
Phosphorus-31 has 100 percent natural abundance and a high gyromagnetic ratio 
which makes it an ideal nucleus for probing the structure and interactions of lipids on a 
microscopic level.  Phosphorus peaks are typically characterized by broad lineshapes 
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which are a result of the chemical shift anisotropy (CSA) due to limited phosphate group 
motion in vesicles. Since chemical bonds are generally magnetically anisotropic, they 
have different susceptibilities along the x, y, and z directions in space. Therefore, the 
magnetic moments induced by the external field Bo are not uniform. The effect of CSA 
can be minimized by the rotational diffusion of the molecule. Since the diffusional 
motion and conformation of the head group can affect the CSA experienced by the 
molecule, the lineshape of the phosphorus resonance is also a function of the motion and 
conformation and provides information about the phase of lipids.42 The 31P NMR 
lineshapes most commonly found in lipid bilayers are characteristic of three types of 
phases, isotropic, hexagonal and lamellar. The lineshape of lipids in the isotropic are 
characterized by narrow sharp resonances. In the case of the phosphorus found in the 
head group of small unilamellar vesicles (< 500 Å), the lineshape is narrow and sharp and 
the result of the fast tumbling and diffusion rates relative to the NMR scale.43  The 
lineshape characteristic of a hexagonal phase is asymmetric and has a slight shoulder on 
the upfield from the peak.  The characteristic lineshape of lamellar phases are also 
asymmetric with a shoulder on the downfield of the resonance. Lipids in the lamellar 
phase often transitioned to the hexagonal phase by increasing water content.32 
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Figure 4-1 Characteristic 31P lineshapes.44-47
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lamellar 
hexagonal 
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At low magnetic field it is possible to observe the resonances from phosphorus in the 
inner and outer leaflet. Since CSA increases with the square of the magnetic field 
strength, at higher magnetic field, the peaks broaden so that the resonances of the inner 
and outer leaflet become indistinguishable. In order to use a higher magnetic field and be 
able to observe the resonances from the inner and outer leaflet, it becomes necessary to 
use a shift reagent to split the resonances. Since phosphorus nuclei, like all magnetic 
nuclei, are sensitive to their chemical environments, their sensitivity to chemical 
surroundings can be exploited with the use of a lanthanide metal shift reagent which does 
not significantly perturb the polar head group conformation.37 Pr3+ is a paramagnetic 
species which interacts with the outer layer of the unilamellar vesicle via a pseudo 
contact process (Figure 4-1). 48 The pseudo contact process is an interaction that exists 
between the magnetic dipole of the paramagnetic species and the phosphorus nuclei 
(Equation 4-1). The resulting change in the resonance frequency is proportional to the 
geometry (ν), and the magnetic dipole moment of the paramagnetic species (K). Contact 
interaction varies inversely with the third power of distance (r).  As a result, the shielding 
of the phosphorus moiety in the head group in the outer leaflet is reduced and the 
phosphorus group relaxes through an alternate pathway with a shortened relaxation time, 
relative to that of a Pr3+ free control, which causes the peak of the outer leaflet to broaden 
and shift downfield. 
Hence, the 31P resonances of DMPC and DMPC-cholesterol unilamellar vesicles are 
split into two signals by the slowly penetrating paramagnetic metal ion Pr3+. The extent to 
which this splitting is attenuated by transdermal penetration enhancers is indicative of the 
extent to which such deep penetration has occurred and has been investigated as a 
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function of the time over which the DMPC and DMPC-cholesterol preparations are 
exposed to Pr3+ utilizing the iminosulfuranes described in Figure 1-4. 
The extent of the iminosulfurane-induced perturbation of the bilayer preparations can 
be observed over time as a reduction in the Pr3+ - mediated 31P resonance separation.  As 
the iminosulfurane-induced perturbation of the bilayer develops, the collapse of the 31P 
resonances suggests that Pr3+ is gaining access to the phosphate groups on the inner 
leaflet on a short distance scale since the contact interaction varies inversely with the 
third power of the distance between the phosphorus moiety and the paramagnetic species 
(Equation 4-1). This observation confirms that the perturbation induced by these 
iminosulfuranes extends to an appreciable extent across the bilayer, i.e. it is a 
transmembrane effect and implies deep penetration of these compounds into the bilayer.   
 
 
 
 
Equation 4-1 Pseudocontact term.48  
∆Dip is shift in resonance frequency. 
K is constant that depends on the magnetic dipole moment of the paramagnetic ion. 
υ is the angle between the paramagnetic ligand and the observed nuclei. 
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Figure 4-2 Interaction of phosphorus nuclei with praseodymium shift reagent.48 
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4.4. Evaluation of Iminosulfurane Activity Using 31P NMR  
 
In the DMPC vesicle system prepared in HEPES buffer with EDTA, concentrations 
of bromo and iodo iminosulfuranes below 1 mole  percent actually impede the collapse of 
peak separation relative to the control suggesting that perhaps there is a threshold 
concentration at which the bromo derivative becomes active similar to DMSO which is 
most effective at 60  percent.  Five mole percent bromo compound provides a marginal 
increase in decay. However, it is within the limits of error for the control. Ten mole 
percent bromo provides a significant increase in the decay of resonance peak separation 
relative to the control. The peak collapses completely to zero which indicates that in the 
presence of 10 mole percent bromo, the Pr 3+ is able to gain access to the inner leaflet of 
the bilayer.  
 
4.5. Effect of Concentration Dependence on Iminosulfurane Activity Using 31P 
NMR  
 
In the DMPC vesicles suspended with HEPES buffer containing EDTA, 
iminosulfurane concentrations below 1 mole percent may actually impede the collapse of 
peak separation relative to the control suggesting that perhaps there is a threshold 
concentration at which the bromo derivative is able to perturb the bilayer. This 
observation is also supported by the DSC heat profiles and NOESY cross peak reported 
by Barrow et al.27  The concentration dependence of efficacy is also a characteristic of 
DMSO which has a threshold concentration at which it is most effective.25  Five mole 
percent bromo compound provides a marginal increase in decay. However, it is within 
the limits of error for the control. Ten mole percent bromo provides a significant increase 
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in the decay of resonance peak separation relative to the control. The peak collapses 
completely to zero, which suggests that in the presence of 10 mole percent bromo, the 
Pr3+ is able to gain access to the inner leaflet of the bilayer.  
One tenth of a percent of iodo derivative seems to have a stabilizing effect on the 
collapse of peak separation, whereas one percent has no effect on the decrease in peak 
separation. Ten mole percent iodo collapses the peak separation to 6 ppm with in 30 
hours. At this concentration, the iodo peak separation does not reach zero. Therefore the 
iodo compound causes less of a bilayer disruption. 
Comparison of the bromo, iodo, and chloro derivatives at 10 mole percent, 10 mole 
percent, and 20 mole percent, respectively, support the biological data that the bromo 
compound is the most active. Additionally, 10 mole percent of bromo caused the collapse 
of peaks within 50 hours. 
These results correlate with the NOESY cross peak data and permeation studies 
(Figures 4-3 and 4-4). Based on the biological activities of the halogenated 
iminosulfuranes, the bromo derivative is the most active, followed by the iodo derivative 
and finally by the chloro derivative, the least active of the series (Figures 4-3).   
Slowly penetrating paramagnetic metal ions differentially shorten the relaxation time 
of the phosphate moieties in the inner and outer leaflets of the lipid bilayers.39 This 
observation further suggests that a perturbation of sufficient extent to accommodate the 
passage of the hydrated form of the Pr3+ is probably developed (i.e., a water channel is 
induced by the iminosulfuranes in order for the highly charged ion to gain access to the 
phosphorus moiety in the inner leaflet of the membrane bilayer).  
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4.6. Effect of Praseodymium Ion on DMPC Liposomes 
 
Since phosphate groups are binding sites for positive metal ions, each vesicle has a 
fixed number of binding sites. 39 Assuming that all phosphate groups in the outer leaflet 
of the bilayer are equally accessible, an increasing metal concentration will eventually 
saturate the available binding sites and cause the peak separation between the inner and 
outer leaflets to reach a maximum.  It is possible that as the Pr3+ concentration 
approaches 4.5 mM, the peak separation approaches a maximum because the sites 
approach maximum capacity.  
Increasing the concentration of Pr3+ results in an increase of peak separation between 
the inner and outer leaflet of the lipid bilayer, because the amount of shielding 
experienced by the phosphate groups in the outer leaflet of the bilayer is greater than that 
of the inner leaflet. As result of the shielding, resonances due to the phosphate groups on 
the outer leaflet shift downfield and broaden. Since the increased concentration of shift 
reagent does not alter the time that it takes for the two resonances to collapse into one 
peak, the peak separation decay rate increases with increasing concentrations.  
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Figure 4-3 Comparison of inverse peak separation and Q24, a measure of biological 
activity of the iminosulfuranes. 
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Figure 4-4 Comparison of  inverse peak separation and cross peak volumes 
measured with the NOESY  DMPC vesicles and  iminosulfurane derivatives. 
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4.7. Interaction of Bromo and Iodo Iminosulfuranes with DMPC Liposomes 
 
In DMPC liposome suspended in HEPES with no EDTA, there is an appearance 
of third peak 16 hours after the addition of shift reagent. Since phosphate lineshapes 
are indicative of a polymorphism of the lipid bilayers, the appearance of an additional 
spectral component indicates that the phosphate group is in a different orientation 
therefore experiencing a different magnetic moment from what is normally found in 
lipids. 49 This spectral components supports the notion that there is a transition of the 
lipid from a bilayer to hexagonal phase, a change that most probably the results from 
movement of the Pr3+ ion across the bilayer.49  Within the 6 hours, the additional 
spectral component disappears and the spectra once again become typical for lipid 
bilayer phases. The shift reagent therefore induces a transient change in phosphate 
head group conformation.50 The effect of 10 mole % of iminosulfuranes, bromo and 
iodo derivatives, on DMPC liposome further supports the biological data and NOESY 
cross peak volumes discussed in sections 1-3 and 4-2, respectively. The peak 
separation of the inner and outer leaflet of the bilayer collapse to zero within 52 
hours. This complete collapse supports the theory that the bromo derivative induces 
the formation of a pore or channel that allows the praseodymium ion to move through 
the bilayer and shield the phosphate groups in the inner leaflet. Conversely, the effect 
of the iodo has a smaller effect on the collapse of peak separation. During the time of 
the experiment, the peak separation decreased from 15 ppm to 8 ppm within 64 hours. 
While the iodo derivative is active, it is not as active as the bromo compound.  
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4.8. Decay of 31P Resonance Separation as a Function of Cholesterol 
Concentration 
 
It has been suggested that cholesterol induces a new state that is different from the gel 
state or the liquid-crystalline state. The new state is referred to as the liquid ordered 
state.33 The presence of the rigid steroid nucleus of cholesterol inserts itself into bilayer 
reducing the number of kinks in the hydrophobic tail of the lipids.33 The reduction of 
kinks in lipids containing less than 18 carbons causes the membrane to thicken. In 
addition to these morphological changes, cholesterol decreases the permeability of small 
molecules across the membrane bilayer. Normally small molecules are able to permeate 
the membrane via transient channels in the bilayer that result from lipids packing 
defects.33 The ordering of the bilayer by cholesterol minimizes these packing defects. 
Consequently, the permeability of small molecules decreases with increasing cholesterol 
content. Finally, the cholesterol interferes with the electrostatic interactions and hydrogen 
bonds that form between phosphate head groups.33  
The decays of 31P resonances were monitored as a function of cholesterol 
concentration. The most obvious change that occurred was the increased stability of the 
system as a result of the increased cholesterol concentration.  The time needed for the 
Pr3+ ion to gain access to the inner leaflet increased with greater cholesterol 
concentration. This observation is supported by the fact that cholesterol reduces the 
permeability of small molecules. The time required for the liposomes to achieve 
maximum peak separation at constant shift reagent concentration was directly 
proportional to the cholesterol concentration. It may be that the interference of 
cholesterol with head group interaction alters the time needed for the Pr3+ ion to bind to 
phosphate groups. 
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4.9. Effect of Iminosulfurane on Liposomes Containing 16 Mole Percent 
Cholesterol 
 
The effect of bromo, iodo, chloro, and hydrogen derivatives on splitting was 
monitored as a function of time over a period of 90 hours in DMPC vesicles containing 
16 mole percent cholesterol. The addition of the bromo derivative caused a collapse of 
the splitting to zero within 30 h and broadened the lineshape of the resonance of the outer 
leaflet. The collapse of peak separation within 30 hours suggests that the 10 mole percent 
bromo induces a change in the bilayer such that the permeability of the praseodymium 
ion is increased relative to that experienced by the control. The characteristic line 
broadening has been suggested to be a consequence of the action of membrane active 
agents.49 The line broadening in this region is explained by idea that part of the lipid 
bilayer is immobilized and disorganized by the presence of a membrane active compound 
such as the bromo derivative of the iminosulfurane. Yet it remains in equilibrium with the 
bilayer.49 Both observations of the bromo derivative support the findings discussed 
earlier. Biological data as well as NOESY cross peak volumes and DSC heat profiles 
indicate that activity of the bromo compound is a function of deep penetration into the 
bilayer and the formation of pores or channels that allow small molecules to move across 
the membrane. 
Ten mole percent of the iodo compound is less active than the bromo, an observation 
that confirms biological data. However based on the decay of peak separations, the iodo 
compound perturbs the bilayer more than the chloro and hydrogen derivatives. 
Examination of the peak shapes after the addition of iodo derivative and comparison to 
the chloro and hydrogen derivatives clearly shows that there is a greater perturbation 
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caused by the iodo compound. The activity of the chloro and hydrogen derivatives is 
minimal in contrast to that of the bromo and iodo derivatives. 
4.10.  Effect of Iminosulfurane on Liposomes Containing 30 Mole Percent 
Cholesterol 
 
The effect of iminosulfurane derivatives on the peak separation was monitored as a 
function of time over a period of 90 hours in DMPC vesicles containing 30 mole percent 
cholesterol.  The addition of iminosulfurane derivatives at 10 and 20 mole percent caused 
a collapse of the splitting that was not significantly different from the control.  This 
observation is a consequence of the ordering and reduced permeability of the membrane 
bilayer caused by the incorporation of cholesterol into the membrane.  However upon 
close examination of the spectra of the bromo and iodo derivatives at 10 and 20 mole 
percents (Figures 3-24, 3-25, 3-27 and 3-28), there is a difference in the linewidths of the 
resonance due to the inner leaflet when compared to that from the control. The bromo and 
iodo derivatives perturb the bilayer to a greater extent than that of the either the chloro or 
hydrogen derivatives as shown by examination of the spectra. 
4.11. Principles of Fluorescence 
 
Fluorescence is one of the types of molecular luminescence spectroscopy that occurs 
when a photon of light is absorbed. The absorbed photons are then emitted in one of two 
ways. The first type of emission is known as resonance fluorescence where the absorbed 
and emitted photon has the same energy or wavelength. The second type is observed 
more often and results from a Stokes’ shift which occurs when the emitted photon has a 
longer wavelength or is less energetic than the absorbed photon.  
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In fluorescence, an electron is excited at a particular wavelength. The excited electron 
moves from the ground state (So) to a vibrational level in the singlet state through a 
nonradiative process. A photon is emitted as the electron falls from the singlet state to the 
ground state (Figure 4-5). The amount of time required for the emission is greater than 
the time required for absorption. However, when compared to phosphorescence, which 
involves a forbidden transition, spin flip inversion, the lifetime for fluorescence is 
relatively short, picoseconds to nanoseconds.  
There are many processes that compete with fluorescence, for example: internal 
conversion, predissociation, external conversion, and intersystem crossing.  Internal 
conversion occurs when the absorbed photon goes to a lower electronic energy state 
nonradiatively. Predissociation and dissociation occur with the rupture of a molecular 
bond and chromophore, respectively. External conversion is a function of the 
environment, because energy transfer between the species, solvent and other surrounding 
molecules can deactivate the excited state. Intersystem crossing is a forbidden process, 
but it does occur when the electron relaxes from an excited singlet to a triplet and 
undergoes spin flip inversion. Despite these competing processes, a molecule that 
fluoresces has several advantages over a molecule that can only be detected by absorption 
spectroscopy. Fluorescence is particularly useful because the linear concentration range is 
greater and more sensitive than absorption spectroscopy.  
4.12. Selection of Fluorophore 
Lipids are devoid of intrinsic fluorescence. Therefore, in order to examine the 
effect of iminosulfuranes on membrane integrity using fluorescence, it becomes 
necessary to use an extrinsic fluorophore. An ideal fluorophore for this system must not 
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bind to the membrane, must undergo self quenching, have a small Stokes shift, and 
absorb in the far red region. Several classes of fluorophores were considered: e.g., 
fluorescein analogs, cyanines, rhodamines, xanathamide fluorescent dyes, fluorescent 
sterols, and styryls. Cyanines, rhodamines, xanathamide, fluorescent dyes, fluorescent 
sterols, and styryls tend to bind or anchor to the lipid bilayers, whereas 
carboxyfluorescein has very little association with membranes. 51-56 
The ideal fluorophore should exhibit a small Stokes Shift, the difference in the 
wavelength between absorbed and emitted quanta (Figure 4-6). The emitted wavelength 
is equal to or longer than the excitation wavelength. Small overlap of excitation and 
emission spectra will permit the fluorescence of the dye to be self-quenched at high 
concentrations such as could exist in the interior of a vesicle. Self- quenching occurs 
when there is a large number of species in solution, resulting in collisions between 
molecules. These collisions cause a radiationless energy transfer. The efficiency of which 
varies inversely with sixth power of the distance between two molecules of the 
fluorophore. This radiationless transfer competes with the fluorescence and hence lowers 
the quantum yield of fluorescing species at high concentrations. The structure of 
carboxyfluorescein is shown in Figure 4-7. It is an ideal fluorophore for this assay in that 
it exhibits minimal association with lipid bilayers, undergoes self-quenching at 
concentrations greater than 100 mM via the formation of dimers (Figure 4-8) and absorbs 
in the far red region of the visible spectrum 
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4.13. Structural Characterization of Vesicles Encapsulated with CF 
The increase in the diameter of the vesicles encapsulated with CF raises the question 
as to why the presence of the dye shifts the diameter to a larger size (Figure 3-37). There 
were two possible considerations that could account for the shift.  The possibilities are 
the osmotic swelling of the vesicles or fusion of two or more vesicles.37  Bammel et al. 
used electron micrographs and T2 relaxation time NMR experiments to determine the 
phenomena responsible for these observations. Electron micrographs showed that vesicle 
fusion continues until all of the vesicles aggregated while there was no minimal 
concentration necessary for the decrease in T2  relaxation times.37 Based on these results, 
it was inferred that vesicle fusion is principally responsible for the increase in diameter.37  
4.14. Stern-Volmer Plots of Bromo and Iodo Derivatives 
The heavy atom effect of halogenated compounds is an important consideration for 
the use of halogenated iminosulfuranes in an assay measuring fluorescence. The Stern-
Volmer plots of the bromo and iodo derivatives had a slope of zero when the 
concentrations of the compounds were in the micromolar range, indicating that the 
diffusional quenching constant is zero. Consequently, there is no heavy atom effect 
exhibited by these compounds in the micromolar range. 
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Figure 4-5 Jablonski diagram. 
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Figure 4-6 Excitation and emission spectra of carboxyfluorescein.57  
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Figure 4-7  Structure of carboxyfluorescein. 
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Figure 4-8 Quenching of carboxyfluorescein at concentrations greater than 100 mM. 
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4.15. Interaction of Triton X-100 on Bilayer Integrity 
 
The CF release curve exhibited an increase in CF release until a plateau was reached, 
when 100 percent of the CF had been released. It has been suggested that nonionic 
surfactant monomers incorporate into the bilayer to induce pore formation or stabilize 
transient pores.58-60  The plateau is achieved when all of the CF has been released. 
Nonionic surfactants are effective TPEs. Understanding the behavior of Triton X-100 is 
important 20 percent (v/v) Triton X-100 is added the ended of the CF quenching assay in 
order to determine the maximum fluorescence intensity (Equation 4-1).  
4.16. Bilayer Integrity Measured by Carboxyfluorescein Release from DMPC 
Vesicles and DMPC Vesicles with Cholesterol 
 
The objective of this assay was to determine the effect of iminosulfurane 
derivatives on the bilayer integrity of vesicles. All CF release curves decrease 
exponentially where the maximum amount of CF is released within the time of mixing 
the sample. The amount of CF released increases linearly with increased concentrations 
of bromo derivative. It is likely that the bromo derivative induces the formation of 
channels in the membrane bilayer by interacting with the polar head groups of the lipid 
matrix and displacing surrounding water molecules similar to DMSO.  The iodo 
derivative causes a CF release that is much smaller than that induced by the bromo 
derivative. These results are supported by the reported biological activity, where the 
bromo derivative is the most active in the series of compound.26 These results are further 
supported by the observation of the effect of these transdermal penetration enhancers on 
the decay of peak separation in the 31P NMR experiments. In the presence of bromo 
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derivative, the Pr3+ was able to gain access to the inner leaflet more quickly than the time 
required to gain access in the presence of the iodo derivative. 
4.17. Summary of Interactions of Iminosulfurane Derivatives  
 
The bromo derivative is the most active iminosulfurane in this series of 
compounds followed by the iodo and chloro derivatives.26 The time course of the 
collapse of the 31P NMR resonance correlates with this activity in that the splitting is 
collapsed most rapidly by the bromo derivative as shown in DMPC and DMPC/ 16 
mole percent cholesterol models. The collapse of the two phosphorus peaks indicates 
that the Pr3+ is able to gain access to the both the outer and inner leaflets on a time 
scale of hours. The collapse of the Pr3+ -split 31P resonances in the presence of 
iminosulfuranes occurs significantly faster than in their absence. This critical 
observation is highly supportive of a mode of action dependent on the deep 
penetration of these iminosulfuranes into the bilayer, but surface interaction with the 
lipids also remains a complementary mechanism for the activity of these transdermal 
penetration enhancers.  
Furthermore, the effect of these molecules on bilayer integrity can be seen with a 
carboxyfluorescein release assay. Results based on the TPE-induced release of 
carboxyfluorescein trapped in the internal volume of DMPC vesicles further indicate 
that these iminosulfuranes disrupt the bilayer sufficiently to allow for the release of 
the fluorophore. The addition of the bromo derivative, the most active compound, 
causes a greater release in CF than that caused by the iodo derivative.   
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4.18. Mechanism of Action of  Halogenated Iminosulfuranes 
 
The mechanism of action supported by the results summarized suggest the active 
iminosulfuranes may act by penetrating the bilayer and inducing channels or pores in the 
membrane that allow for the movement of small molecules across the bilayer in the 
presence and absence of cholesterol. The incorporation of cholesterol at 16 mole percent 
stabilized the lipid bilayer and made it easier to see the effect of the iminosulfurane 
derivatives, whereas 30 mole percent cholesterol almost completely sealed the bilayer so 
that was the difference between the types and concentrations of iminosulfuranes were 
almost indistinguishable. The differential in the TPE activity of the bromo in contrast to 
that of the other three derivatives may be a result of enhanced residence time of the 
bromo derivative in the bilayer.  
4.19. Further Studies on Halogenated Iminosulfuranes 
 
The overarching question that needs to be answered is why the bromo derivative is the 
most active in this series of halogenated iminosulfuranes. Based solely on 
electronegativity, the expectation would be that the fluoro derivative would be the most 
biologically active. However, the fluoro derivative is biologically inactive. In contrast, 
comparison of relative size would support the iodo derivative being the most biologically 
active in this series.  Since the neither the fluoro derivative or the iodo derivative are the 
most active, there must be other physico-chemical considerations that make the bromo 
derivative the most effective transdermal penetration enhancer. Perhaps, the bromo 
derivative has more available binding sites on the bilayer than the other derivatives which 
would cause an appreciable increase in the amount of channels induced in the DMPC 
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membrane. As a result, the number of channels induced in the membrane would be 
directly proportional to the amount of drug able to permeate the lipid matrix of the skin.  
Binding studies and scatchard analysis of iminosulfurane derivatives present in different 
concentrations may provide further insight into the increased efficacy of the bromo 
derivative relative to the other halogenated iminosulfuranes. The great extent to which 
the bromo derivative perturbs the bilayer may also be a function of the nature of the 
halogen oxygen bonds that may form with the iminosulfurane derivative. 
Characterization and comparison of these bonds may further support the biological 
activity of this series of iminosulfuranes. 
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